Dealing with Autosomal Dominant Polycystic Kidney Disease (ADPKD) episode artwork

EPISODE · Aug 4, 2025 · 5 MIN

Dealing with Autosomal Dominant Polycystic Kidney Disease (ADPKD)

from MedEvidence Articles · host MedEvidence Articles

On this week's episode, we look at an increasingly full house of treatments which are being developed to join the club of autosomal dominant polycystic kidney disease medications. We look at what ADPKD is, who it affects, and what kinds of treatments on the horizon may be a diamond in the rough. Find out all about ADPKD in this fun podcast that raises spirits, suits a quest for knowledge, and doesn't bluff about this condition!References:Cornec-Le Gall, E., Alam, A., & Perrone, R. D. (2019). Autosomal dominant polycystic kidney disease. The Lancet, 393(10174), 919-935. https://www.proquest.com/docview/2186986383?accountid=14690Jdiaa, S. S., Mustafa, R. A., & Alan, S. L. (2025). Treatment of autosomal-dominant polycystic kidney disease. American Journal of Kidney Diseases, 85(4), 491-500. https://www.sciencedirect.com/science/article/pii/S0272638624010321Koren, M. J., Chebib, M. (16 July, 2025). What's on the horizon for polycystic kidney disease (PKD)? On MedEvidence! Truth Behind the Data. [Podcast]. https://medevidence.com/whats-on-the-horizon-for-polycystic-kidney-disease-pkdChebib, F. T., & Torres, V. E. (2018). Recent advances in the management of autosomal dominant polycystic kidney disease. Clinical Journal of the American Society of Nephrology, 13(11), 1765-1776. https://pmc.ncbi.nlm.nih.gov/articles/PMC6237066/Reiterová, J., & Tesař, V. (2022). Autosomal dominant polycystic kidney disease: from pathophysiology of cystogenesis to advances in the treatment. International journal of molecular sciences, 23(6), 3317. https://www.mdpi.com/1422-0067/23/6/3317Kashyap, S., Zeidler, J. D., Chini, C. C., & Chini, E. N. (2020). Implications of the PAPP-A-IGFBP-IGF-1 pathway in the pathogenesis and treatment of polycystic kidney disease. Cellular signalling, 73, 109698. https://www.sciencedirect.com/science/article/abs/pii/S0898656820301753Share with a friend. Rate, Review, and Subscribe to MedEvidence! Articles to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramTwitterLinkedInTiktokYoutubeFor more great content, including discussions by physicians and clinical research experts, check out the MedEvidence! Podcast and MedEvidence.comThank you for listening!

Episode metadata supplied by the publisher feed · Published Aug 4, 2025

Embed this episode

On this week's episode, we look at an increasingly full house of treatments which are being developed to join the club of autosomal dominant polycystic kidney disease medications. We look at what ADPKD is, who it affects, and what kinds of treatments on the horizon may be a diamond in the rough. Find out all about ADPKD in this fun podcast that raises spirits, suits a quest for knowledge, and doesn't bluff about this condition! References: Cornec-Le Gall, E., Alam, A., & Perrone, R. D. ...

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

Dealing with Autosomal Dominant Polycystic Kidney Disease (ADPKD)

0:00 5:52

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of MedEvidence Articles?

This episode is 5 minutes long.

When was this MedEvidence Articles episode published?

This episode was published on August 4, 2025.

Can I download this MedEvidence Articles episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!